ATIN — Athanase Innovation AB Balance Sheet
0.000.00%
- SEK343.50m
- SEK43.31m
- SEK115.27m
- 45
- 28
- 13
- 15
Annual balance sheet for Athanase Innovation AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 June 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14.9 | 747 | 644 | 457 | 311 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.3 | 3.97 | 6.47 | 7.84 | 14.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 22.3 | 755 | 662 | 502 | 344 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 0.243 | 1 | 0.861 | 2.05 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 677 | 919 | 827 | 683 | 552 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.8 | 10.7 | 34.8 | 48.8 | 67.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 433 | 11.3 | 35.4 | 49.1 | 67.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 244 | 907 | 792 | 634 | 485 |
Total Liabilities & Shareholders' Equity | 677 | 919 | 827 | 683 | 552 |
Total Common Shares Outstanding |